Ana Morice

597 total citations
24 papers, 354 citations indexed

About

Ana Morice is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Ana Morice has authored 24 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Health and 7 papers in Infectious Diseases. Recurrent topics in Ana Morice's work include Vaccine Coverage and Hesitancy (11 papers), Virology and Viral Diseases (10 papers) and Syphilis Diagnosis and Treatment (6 papers). Ana Morice is often cited by papers focused on Vaccine Coverage and Hesitancy (11 papers), Virology and Viral Diseases (10 papers) and Syphilis Diagnosis and Treatment (6 papers). Ana Morice collaborates with scholars based in United States, Costa Rica and Cuba. Ana Morice's co-authors include Carlos Castillo‐Solórzano, Susan E. Reef, María L. Ávila-Agüero, Rolando Ulloa‐Gutiérrez, Michael Edelstein, Noni E. MacDonald, Jaleela S. Jawad, Heather M. Scobie, M. Carolina Danovaro‐Holliday and Edward Nicol and has published in prestigious journals such as SHILAP Revista de lepidopterología, Philosophical Transactions of the Royal Society B Biological Sciences and The Journal of Infectious Diseases.

In The Last Decade

Ana Morice

23 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Morice United States 10 218 172 83 70 50 24 354
Elizabeth Rausch-Phung United States 8 328 1.5× 291 1.7× 134 1.6× 50 0.7× 27 0.5× 12 410
Jennifer K. Knapp United States 8 183 0.8× 98 0.6× 106 1.3× 55 0.8× 33 0.7× 13 269
P.A. Litton United Kingdom 7 265 1.2× 127 0.7× 78 0.9× 26 0.4× 26 0.5× 7 304
Berhanu G. Gebremeskel United States 5 622 2.9× 170 1.0× 118 1.4× 29 0.4× 48 1.0× 7 790
Xinghuo Pang China 13 357 1.6× 108 0.6× 106 1.3× 45 0.6× 12 0.2× 34 445
Myriam Ben Mamou Denmark 10 267 1.2× 122 0.7× 86 1.0× 17 0.2× 33 0.7× 17 319
Alla Heider Germany 10 378 1.7× 75 0.4× 127 1.5× 71 1.0× 38 0.8× 15 444
Cinzia Piovesan Italy 11 130 0.6× 82 0.5× 208 2.5× 31 0.4× 20 0.4× 17 422
Yiguo Zhou China 8 119 0.5× 101 0.6× 166 2.0× 19 0.3× 26 0.5× 38 333
Amy A. Parker United States 3 150 0.7× 137 0.8× 62 0.7× 31 0.4× 13 0.3× 5 286

Countries citing papers authored by Ana Morice

Since Specialization
Citations

This map shows the geographic impact of Ana Morice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Morice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Morice more than expected).

Fields of papers citing papers by Ana Morice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Morice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Morice. The network helps show where Ana Morice may publish in the future.

Co-authorship network of co-authors of Ana Morice

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Morice. A scholar is included among the top collaborators of Ana Morice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Morice. Ana Morice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ávila-Agüero, María L., et al.. (2025). Human Papilloma Virus Vaccination as a Strategy to Eliminate Cervical Cancer: Challenges and Opportunities. Vaccines. 13(3). 297–297. 2 indexed citations
2.
Cox, Horace, et al.. (2024). Factors associated with never treatment and acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana, 2021. SHILAP Revista de lepidopterología. 4(4). e0001985–e0001985. 1 indexed citations
3.
Morice, Ana, María Paz Ade, Gloria Rey-Benito, et al.. (2023). Lessons learned from the implementation of integrated serosurveillance of communicable diseases in the Americas. Revista Panamericana de Salud Pública. 47. 1–1. 5 indexed citations
4.
Diggle, Peter J., et al.. (2023). Modernizing the design and analysis of prevalence surveys for neglected tropical diseases. Philosophical Transactions of the Royal Society B Biological Sciences. 378(1887). 20220276–20220276. 1 indexed citations
5.
Morice, Ana, et al.. (2023). Health workers vaccination: Experience and lessons learned from Costa Rica. Vaccine X. 15. 100376–100376.
6.
Scobie, Heather M., Michael Edelstein, Edward Nicol, et al.. (2020). Improving the quality and use of immunization and surveillance data: Summary report of the Working Group of the Strategic Advisory Group of Experts on Immunization. Vaccine. 38(46). 7183–7197. 63 indexed citations
7.
Morice, Ana, et al.. (2017). Experiencia del desarrollo de herramientas para el monitoreo de coberturas de vacunación y quimioterapia preventiva. Revista Panamericana de Salud Pública. 41. 1–8. 1 indexed citations
8.
Teixeira, Antônia Maria da Silva, et al.. (2011). Brazilian experience with rapid monitoring of vaccination coverage during a national rubella elimination campaign.. PubMed. 30(1). 7–14. 9 indexed citations
9.
Morice, Ana, et al.. (2011). Approach to Verify the Status of Measles, Rubella, and Congenital Rubella Syndrome Elimination in Costa Rica. The Journal of Infectious Diseases. 204(suppl_2). S690–S697. 4 indexed citations
10.
Castillo‐Solórzano, Carlos, et al.. (2011). Guidelines for the Documentation and Verification of Measles, Rubella, and Congenital Rubella Syndrome Elimination in the Region of the Americas. The Journal of Infectious Diseases. 204(suppl_2). S683–S689. 37 indexed citations
11.
Castillo‐Solórzano, Carlos, Susan E. Reef, Ana Morice, et al.. (2011). Rubella Vaccination of Unknowingly Pregnant Women During Mass Campaigns for Rubella and Congenital Rubella Syndrome Elimination, The Americas 2001-2008. The Journal of Infectious Diseases. 204(suppl 2). S713–S717. 35 indexed citations
12.
Metcalf, C. Jessica E., Justin Lessler, Petra Klepac, et al.. (2011). Structured models of infectious disease: Inference with discrete data. Theoretical Population Biology. 82(4). 275–282. 28 indexed citations
13.
Morice, Ana, et al.. (2011). Measles Outbreak in Venezuela: A New Challenge to Postelimination Surveillance and Control?. The Journal of Infectious Diseases. 204(suppl_2). S675–S682. 6 indexed citations
14.
Morice, Ana, Rolando Ulloa‐Gutiérrez, & María L. Ávila-Agüero. (2009). Congenital rubella syndrome: progress and future challenges. Expert Review of Vaccines. 8(3). 323–331. 28 indexed citations
15.
Morice, Ana, et al.. (2008). Mitos, creencias y realidades sobre las vacunas. 20(2). 60–64. 4 indexed citations
16.
Ávila-Agüero, María L., et al.. (2007). Estimating the Burden of Congenital Rubella Syndrome in Costa Rica, 1996–2001. The Pediatric Infectious Disease Journal. 26(5). 382–386. 15 indexed citations
17.
Morice, Ana, et al.. (2007). Fetal Risk Associated With Rubella Vaccination During Pregnancy. The Pediatric Infectious Disease Journal. 26(9). 830–835. 35 indexed citations
18.
Morice, Ana, et al.. (2005). Tendencias de la inmunidad a la rubéola en mujeres de edad fértil y pre-escolares en Costa Rica 1969-1996. 19(1). 13–18. 5 indexed citations
19.
Morice, Ana, et al.. (2004). Uso de encuestas en escolares para la evaluación de la cobertura y oportunidad de la vacunación en Costa Rica. Revista Panamericana de Salud Pública. 16(2). 118–124. 7 indexed citations
20.
Morice, Ana, et al.. (2003). Tendencias, costos y desafíos para la atención de las enfermedades crónicas en Costa Rica. 11(1). 18–34. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Rausch-Phung Breakdown of academic impact, for papers by Jennifer K. Knapp Breakdown of academic impact, for papers by P.A. Litton Breakdown of academic impact, for papers by Berhanu G. Gebremeskel Breakdown of academic impact, for papers by Xinghuo Pang Breakdown of academic impact, for papers by Myriam Ben Mamou Breakdown of academic impact, for papers by Alla Heider Breakdown of academic impact, for papers by Cinzia Piovesan Breakdown of academic impact, for papers by Yiguo Zhou Breakdown of academic impact, for papers by Amy A. Parker
Rankless by CCL
2026